Maximilien Levesque is the founder of AQEMIA. AQEMIA has raised $100M in total funding. Latest round: Series A. Based in Paris, France.
Maximilien Levesque is the Co-founder and CEO of AQEMIA, a techbio company that was co-founded in 2019. The company uses quantum and statistical physics combined with generative AI to design novel drug candidates. AQEMIA has raised over $100 million in cumulative funding.
Full founder directory · Investor directory · Company funding database · Fundraising library